Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent Glioblastoma
Clinical trial NCT02010606 · COMPLETED
Trial details
- NCT number
- NCT02010606
- Sponsor
- Cedars-Sinai Medical Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-08
- Primary completion
- 2019-01-23
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.